Sequential vs concurrent adjuvant chemotherapy of anthracycline and taxane for operable breast cancer

BACKGROUND: Whether a sequential or concurrent regimen of anthracyclines and taxanes is superior for breast cancer is controversial. We compared the efficacy of two regimens in patients with operable breast cancer based on all relevant published data of phase III randomized controlled trials. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Wanjing, Tu, Qian, Shen, Yanfei, Tang, Kejun, Hong, Mengying, Shen, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890894/
https://www.ncbi.nlm.nih.gov/pubmed/33602236
http://dx.doi.org/10.1186/s12957-021-02150-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890894/
https://www.ncbi.nlm.nih.gov/pubmed/33602236
http://dx.doi.org/10.1186/s12957-021-02150-4

Ejemplares similares